Substrate recognition by P-glycoprotein and the multidrug resistance-associated protein MRP1: a comparison

被引:1
作者
Seelig, A [1 ]
Blatter, XL [1 ]
Wohnsland, F [1 ]
机构
[1] Univ Basel, Bioctr, Dept Biophys Chem, CH-4056 Basel, Switzerland
关键词
multidrug resistance; P-glycoprotein (P-gp); multidrug resistance-associated protein (MRP1); substrate specificity; hydrogen bonds; substrate recognition;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objectives: It has recently been suggested that substrate recognition patterns for human P-glycoprotein encoded by mdr1 consist of two electron donor groups with a spatial separation of 2.5 +/- 0.3 Angstrom (type I units) or three electron donor groups with a spatial separation of the two outer groups of 4.6 +/- 0.6 Angstrom (type II units) [Seelig 1998]. Since P-gp and the multidrug resistance-associated protein (MRP1)have overlapping substrate specificity, we screened the chemical structures of 21 compounds, previously tested as MRP1 substrates, for electron donor units. In addition, we searched the putative transmembrane domains (TMD 1 - 12) of P-gp and (TMD 6-17) of MRP 1 for amino acid side chains having the potential to interact with the respective substrates. Methods: The three-dimensional structures of potential MRP I substrates were modeled with a force-field approach and were then screened for electron donor units. Helical wheel projections of the 12 putative transmembrane domains of P-gp (1 - 12) and MRP (6 - 17)were analyzed for their content of amino acid residues with hydrogen bonding side chains, charged amino acid residues, and amino acid residues with pi-electron systems. Results: MRP1 recognizes compounds with type I and type IT units. At least one electrically neutral together with either one negatively charged type I unit or two electrically neutral type I units are required for the compound to be bound and transported. Transport increases with increasing number of electron donor units. Compounds which carry exclusively electrically neutral type I units (P-gp substrates) are transported only weakly by MRP1, and compounds with cationic type I units (P-gp substrates) are not transported at all. An analysis of the putative transmembrane alpha-helices of MRP1 and P-gp reveals that the amino acid residues with hydrogen-bond donor side chains are arranged preferentially on one side of the helix and amino acid residues with inert (non-hydrogen-bonding) side chains on the other side. In the case of MRP1, the hydrogen-bonding face also contains several cationic residues whereas, in the case of P-gp, it contains clusters of amino acid residues with pi-electron systems. Conclusions: We propose that P-gp and MRP 1 recognize type I or type TI units in chemical compounds having diverse structures, and that these transporters bind their substrates via hydrogen bond formation. Furthermore, we propose that transport of anionic substrates by MRP I is facilitated by cationic amino acid residues present in the transmembrane helices of MRP I, whereas the transport of cationic substrates by P-gp is facilitated by a pi-electron slide guide.
引用
收藏
页码:111 / 121
页数:11
相关论文
共 38 条
[1]   Membrane topology and glycosylation of the human multidrug resistance-associated protein [J].
Bakos, E ;
Hegedus, T ;
Hollo, Z ;
Welker, E ;
Tusnady, GE ;
Zaman, GJR ;
Flens, MJ ;
Varadi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12322-12326
[2]   Functional multidrug resistance protein (MRP1) lacking the N-terminal transmembrane domain [J].
Bakos, E ;
Evers, R ;
Szakács, G ;
Tusnády, GE ;
Welker, E ;
Szabó, K ;
de Haas, M ;
van Deemter, L ;
Borst, P ;
Váradi, A ;
Sarkadi, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (48) :32167-32175
[3]   Multidrug resistance protein-mediated transport of chlorambucil and melphalan conjugated to glutathione [J].
Barnouin, K ;
Leier, I ;
Jedlitschky, G ;
Pourtier-Manzanedo, A ;
König, J ;
Lehmann, WD ;
Keppler, D .
BRITISH JOURNAL OF CANCER, 1998, 77 (02) :201-209
[4]   Human mast cells secreting leukotriene C4 express the MRP1 gene-encoded conjugate export pump [J].
Bartosz, G ;
König, J ;
Keppler, D ;
Hagmann, W .
BIOLOGICAL CHEMISTRY, 1998, 379 (8-9) :1121-1126
[5]   EFFECTS OF INDOLE ALKALOIDS ON MULTIDRUG RESISTANCE AND LABELING OF P-GLYCOPROTEIN BY A PHOTOAFFINITY ANALOG OF VINBLASTINE [J].
BECK, WT ;
CIRTAIN, MC ;
GLOVER, CJ ;
FELSTED, RL ;
SAFA, AR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 153 (03) :959-966
[6]   Do cMOAT (MRP2), other MRP homologues, and LRP play a role in MDR? [J].
Borst, P ;
Kool, M ;
Evers, R .
SEMINARS IN CANCER BIOLOGY, 1997, 8 (03) :205-213
[7]  
BURKERT U, 1982, ACS MONOGRAPH, V177
[8]   CHEMISTRY AND BIOLOGY OF N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)-LABELED LIPIDS - FLUORESCENT-PROBES OF BIOLOGICAL AND MODEL MEMBRANES [J].
CHATTOPADHYAY, A .
CHEMISTRY AND PHYSICS OF LIPIDS, 1990, 53 (01) :1-15
[9]   OVEREXPRESSION OF A TRANSPORTER GENE IN A MULTIDRUG-RESISTANT HUMAN LUNG-CANCER CELL-LINE [J].
COLE, SPC ;
BHARDWAJ, G ;
GERLACH, JH ;
MACKIE, JE ;
GRANT, CE ;
ALMQUIST, KC ;
STEWART, AJ ;
KURZ, EU ;
DUNCAN, AMV ;
DEELEY, RG .
SCIENCE, 1992, 258 (5088) :1650-1654
[10]   MULTIDRUG-RESISTANCE GENE (P-GLYCOPROTEIN) IS EXPRESSED BY ENDOTHELIAL-CELLS AT BLOOD-BRAIN BARRIER SITES [J].
CORDONCARDO, C ;
OBRIEN, JP ;
CASALS, D ;
RITTMANGRAUER, L ;
BIEDLER, JL ;
MELAMED, MR ;
BERTINO, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (02) :695-698